Announces $10 Million Bought Deal Offering Of Common Stock Business | AIkido Pharma Inc. | February 16, 2021 AIkido Pharma Enters Into Letter Of Intent With Silo Pharma for Use of Psilocybin and Peptide Therapy for Cancer Treatment AIkido Pharma Increases Bought-Deal Offering to $75 Million 3:52AM ET 2/17/2021 MT Newswires. AIkido Pharma Inc. (NASDAQ:AIKI) traded at $1.08 at last check on Monday, June 14, made a downward move of -0.92% on its previous day’s price. NEW YORK, Feb. 19, 2021 -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced the closing of its previously announced underwritten public offering of 46,875,000 shares of its common stock at a price to the public of $1.60 per share. In that particular session, Stock kicked-off at the price of $1.04 while reaching the peak value of $1.06 and lowest value recorded on the day was $1.03. PR Newswire +5.19%. The company’s stock price has collected 3.81% of gains in the last five trading sessions. Announces $10 Million Bought Deal Offering Of Common Stock. Announces Closing of $75 Million Bought Deal Offering of Common Stock Article Stock Quotes (1) FREE Breaking News Alerts from StreetInsider.com! Get the latest AIkido Pharma Inc. (AIKI) stock news and headlines to help you in your trading and investing decisions. NEW YORK, May 8, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that Hoth Therapeutics Inc. registered the stock to … AIkido Pharma Inc. had a pretty favorable run when it comes to the market performance. AIkido Pharma Inc. (NASDAQ:AIKI) has a beta value of 1.58 and has seen 3.12 million shares traded in the last trading session. Announces Closing of $75 Million Bought Deal Offering of Common Stock. Annual stock financials by MarketWatch. AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of Common Stock to $75 Million. AIKIDO PHARMA INC. : Financial news and information Stock AIKIDO PHARMA INC. | Nasdaq: AIKI | Nasdaq Re: AIkido Pharma Inc. Dear Mr. Jaegers; Please vote my shares of AIkido Pharma Inc. Common Stock for the 2020 Annual Meeting of Stockholders as follows: FOR the amendment to effect reverse stock split ; Proposals 2, 3a,3b,3c,3d, 3e, 3f, 4, 5, and 6 will be voted FOR in order to complete the proxy. 0.02; 1.82%; Volume: 3.7 Mil . Regains Compliance with NASDAQ Listing Requirements. Please vote my shares of AIkido Pharma Inc. Common Stock for the 2020 Annual Meeting of Stockholders as follows: ... About AIkido Pharma Inc.AIkido Pharma Inc. was initially formed in … At the end of the trading day, the stock’s price was $1.05, reflecting an intraday loss of -2.78% or -$0.03. 1.05-0.11-9.48%. Announces Closing of $75 Million Bought Deal Offering of Common Stock. AIkido Pharma Inc. During the last session, AIkido Pharma Inc. (NASDAQ:AIKI)’s traded shares were 3.8 million, with the beta value of the company hitting 1.57. FORM 10-Q. Get the latest EPS stock quote information from Zacks Investment Research. AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of Common Stock to $75 Million. See Also: Best Biotech Penny Stocks The Aikido Pharma Chart: Aikido’s stock is down almost 60% from its 10-month high it made on Feb. 16. Get information about Aikido Pharma Inc. - Common Stock 1 full quote, overview, rates, charts, news and more | NetDania.com Aikido Pharma Inc (NASDAQ: AIKI) has increased the size of the previously announced public offering to 46.8 million shares at $1.60 per share, with gross proceeds of $75 million. The previous offering i... The Company is focused on developing a diverse portfolio of small-molecule anti-cancer therapeutics. Regains Compliance with NASDAQ Listing Requirements.. Get the hottest stocks to trade every day before the market opens 100% free. NEW YORK, April 30, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced a reminder to the Company's stockholders that today, April 30, 2020, is the record date for the previously announced distribution to our stockholders of shares of common stock of Hoth Therapeutics, Inc. ("Hoth").Each stockholder of the Company, as of 4:00 p.m. … Company profile page for AIkido Pharma Inc including stock price, company news, press releases, executives, board members, and contact information Find the latest news headlines from AIkido Pharma Inc. Common Stock (AIKI) at Nasdaq.com. The company, currently valued at $95.80M, closed the last trade at $1.09 per share which meant it gained $0.02 on the day or 1.87% during that session. The information contained therein may be updated, amended, supplemented or otherwise altered by subsequent presentations, reports and/or filings by AIkido Pharma Inc. NEW YORK , Feb. 16, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 46,875,000 shares of common stock of the Company at a price to the public of $1.60 per share, less … AIkido Pharma Inc. (AIKI) full … AIKI is not currently paying a regular dividend. The total number of shares of a security that have been sold short and not yet repurchased. Percentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month. Total short positions relative to the number of shares available to trade. AIkido Pharma Inc. is a biotechnology development company working to develop a diverse portfolio of early and mid-stage small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. AIkido Pharma Inc. had a pretty favorable run when it comes to the market performance. AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of Common Stock to $75 Million. SECURITIES AND EXCHANGE COMMISSION. AIkido Pharma Inc. Find the latest AIkido Pharma Inc. (AIKI) stock quote, history, news and other vital information to help you with your stock trading and investing. The company report on January 22, 2021 that AIkido Pharma Inc. Feb-16-21 10:15PM. The 1-year high price for the company’s stock is recorded $2.5500 on 02/16/21, with the lowest value was $0.8000 for the same time period, recorded on 01/04/21. Find the latest Earnings Yield (TTM) for AIkido Pharma Inc. (AIKI) The company report on January 22, 2021 that AIkido Pharma Inc. Get the latest Aikido Pharma Inc (AIKI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. The stock current value is $1.12. At the Meeting, the Company's did not obtain the approval from stockholders that held a majority of the issued and outstanding shares of common stock as of the … NEW YORK, Feb. 23, 2021-- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the underwriter of its previously announced bought deal offering of common stock has partially exercised its option to purchase an additional 7,030,927 shares of common stock at a price to the public of $1.60 per share. AIkido Pharma Inc. [NASDAQ: AIKI] stock went on an upward path that rose over 46.72% on Tuesday, amounting to a one-week price increase of more than 62.73%. AIkido Pharma Inc. AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that Dr. Matthew Frieman has joined the Company's Scientific Advisory Board. Company Profile. AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 46,875,000 shares of common stock of the Company at a price to the public of $1.60 per share, less underwriting discounts and commissions. Quote. S&P 500 0.92%. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Email Print Tweet. View today's stock price, news and analysis for AIkido Pharma Inc. (AIKI). AIkido Pharma … AIkido Pharma Inc. earnings are expected to increase by 73.6% in 2021, but … NEW YORK, April 20, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ( AIkido Pharma Inc (AIKI) Stock Quote and News . AIkido Pharma Inc. Common Stock (AIKI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced the closing of its previously announced underwritten public offering of 46,875,000 shares of its common stock at a price to the public of $1.60 per share. At the end of the latest market close, AIkido Pharma Inc. (AIKI) was valued at $1.05. ... Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of … Selected key stats of AIkido Pharma Inc. (AIKI) including 10 year stock price and latest news. Its diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Trending now. AIkido Pharma Inc. Common Stock. Please wait while we load your information from QuoteMedia. We use our internally-built news screening methodology to estimate the value of AIKIDO PHARMA based on different types of headlines from major news networks to social media. Earnings Yield (TTM) is a widely used stock evaluation measure. The 1-year high price for the company’s stock is recorded $2.5500 on 02/16/21, with the lowest value was $0.8000 for the same time period, recorded on 01/04/21. Volume % Chg: 0%; Get a Leaderboard Chart for AIKI? Furthermore, AIkido Pharma Inc. (AIKI)’s beta value is 1.57, and its average true range (ATR) is 0.08. AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of Common Stock to $75 Million Provided by PR Newswire Feb 17, 2021 3:15 AM UTC As previously announced, the Company has granted to the underwriter a 30-day option to purchase up to 7,031,250 additional shares of common stock at … Get the hottest stocks to trade every day … It has also generated negative returns for investors over the last 90 days. AIKI: AIkido Pharma Inc. EPS. View the latest BP2M financial statements, income statements and financial ratios. A high-level overview of AIkido Pharma Inc. (AIKI) stock. NASDAQ 1.76%. Item 5.07 Submission of Matters to a Vote of Security Holders. Stock quote and company snapshot for AIKIDO PHARMA INC (AIKI), including profile, stock chart, recent news and events, analyst opinions, and research reports. News provided by AIkido Pharma Inc. Mar 13, 2020, 13:42 ET ... Each AIkido stockholder will be entitled to receive one (1) share of Hoth common stock for every seventy (70) shares of AIkido common stock held as of 5 p.m. Eastern Time on March 16, 2020, the new record date. AIkido Pharma Provides Update on its Antiviral Platform, Including the Virus That Causes COVID-19 PR Newswire 02/22 09:00 ET AIkido Pharma Inc. Re: AIkido Pharma Inc. At the Meeting, the Company's did not obtain the approval from stockholders that held a majority of the issued and outstanding shares of common stock as of the … Dear Mr. Jaegers; Please vote my shares of AIkido Pharma Inc. Common Stock for the 2020 Annual Meeting of Stockholders as follows: FOR the amendment to effect reverse stock split; Proposals 2, 3a,3b,3c,3d, 3e, 3f, 4, 5, and 6 will be voted FOR in order to complete the proxy. AIkido Pharma 1.05 0.11 (9.48%) AIkido Pharma NASDAQ Updated Jun 4, 2021 4:59 PM. AIkido Pharma Inc. AIkido Pharma Inc. Delayed (15 Min) Trade Data: 12:00am 06/04/2021. AIkido Pharma Inc (NASDAQ: AIKI) is having yet another strong day in the market today.After a strong climb in value yesterday, led by the licensing of COVID-19 related technology, investors are excited about funds that are being raised at a premium.Here’s what’s happening: Aikido and Brickell are also two heavily traded penny stocks in the Robinhood community. Get the hottest stocks to trade every day before the market opens 100% free. AIkido Pharma Inc. Click here now. AIKI. Item 5.07 Submission of Matters to a Vote of Security Holders. AIkido Pharma Inc. is a biotechnology development company with a diverse portfolio of early stage small-molecule anti-cancer therapeutics. This is a 0.94 percent increase since the beginning of the trading day. PR Newswire +5.19%. The stock's open price was 1.06.AIkido Pharma has a very high chance of experiencing financial distress in the next few years of operation. AIkido Pharma Inc. to Present at the Benzinga Global Small Cap Conference, the Investor Summit Group's Conference, and the LD Micro Invitational Conference Press Release 05/11/21 AIkido Pharma Inc. will not be reviewing or updating the material that is contained in these items after the date thereof. Announces Closing of $75 Million Bought Deal Offering of Common Stock Get the hottest stocks to Washington, D.C. 20549. During the last session, AIkido Pharma Inc. (NASDAQ:AIKI)’s traded shares were 3.8 million, with the beta value of the company hitting 1.57. Key stats provide selected financials for rapid company overview including revenues, marketcap, P/E ratio, debt and much more. February 23, 2021 - 10:56 am. AIkido Pharma Inc. Press Release reported on 06/04/21 that AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591. AIkido Pharma Inc. seeks to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with its shareholders. It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. The AIKI stock … AIkido Pharma Inc. Common Stock, also called AIkido Pharma, is a biotechnology development company, which engages in the provision of diversified portfolio of small-molecule anticancer and antiviral therapeutics in development. AIkido Pharma Increases Bought-Deal Offering to $75 Million 3:52AM ET 2/17/2021 MT Newswires. The company’s stock has been forecasted to trade at an average price of $1802.25 over the course of the next 52 weeks, with a low of $1802.25 and a high of $1802.25. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … Daily Weekly. See How IBD Rates . Annual Meeting . Annual Meeting. At the end of the trading day, the stock’s price was $1.05, reflecting an intraday loss of -2.78% or -$0.03. AIkido Pharma Inc. [NASDAQ: AIKI] gained 18.31% or 0.26 points to close at $1.68 with a heavy trading volume of 29403669 shares. On January 12, 2021, AIkido Pharma Inc., a Delaware corporation (the "Company"), reconvened its 2020 annual meeting of stockholders (the "Meeting"). NEW YORK, Feb. 19, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced the closing of its previously announced underwritten public offering of 46,875,000 shares of its common stock at a price to the public of $1.60 per share. Real-time exchange rate quote of Aikido Pharma Inc. - Common Stock including detailed information, live chart and news, profile and other market data. Aikido Pharma Inc., formerly Spherix Incorporated, is a biotechnology company. AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 46,875,000 shares of common stock of the Company at a price to the public of $1.60 per share, less underwriting discounts […] The company's pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia. Aikido Pharma Inc., formerly Spherix Incorporated, is a biotechnology company. Announces $10 Million Bought Deal Offering Of Common Stock finance.yahoo.com - February 16 at 5:06 PM AIkido Pharma Enters Into Letter Of Intent With Silo Pharma for Use of Psilocybin and Peptide Therapy for Cancer Treatment Get the hottest stocks to trade every day before the market opens 100% free. AIkido Pharma Inc. (AIKI) full year performance was 47.95% The Company is focused on developing a diverse portfolio of small-molecule anti-cancer therapeutics. AIkido Pharma Inc. NEW YORK, Feb. 16, 2021 AIkido Pharma Inc. (AIKI) today announced that due to demand, the underwriter has agreed to incre... AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of Common Stock to $75 Million NEW YORK, Feb. 19, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced the closing of its previously announced underwritten public offering of 46,875,000 shares of its common stock at a price to the public of $1.60 per share. AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of Common Stock to $75 Million Provided by PR Newswire Feb 17, 2021 3:15 AM UTC GET QUOTE $ 1.08. It looks to have put in a bottom at the 80-cent mark and by Wednesday morning had rebounded 32% from that level to $1.03. Overview. Feb-16-21 10:15PM. Aikido Pharma Inc. (Form: 10-Q, Received: 05/14/2020 16:07:29) UNITED STATES. Stock Information for AIkido Pharma Inc. Loading . AIkido Pharma Inc. (Nasdaq: AIKI) News & Media - Detail View. AIkido Pharma Inc. (NASDAQ:AIKI) went up by 1.87% from its latest closing price compared to the recent 1-year high of $2.55. AIkido Pharma secures $75M via equity raise Seeking Alpha - 2/17/2021 12:27:41 AM: AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of Common Stock to $75 Million PR Newswire (US) - 2/16/2021 10:15:00 PM: AIkido Pharma to raise $10M through bought deal offering Seeking Alpha - 2/16/2021 4:52:28 PM GuruFocus Article or News written by PRNewswire and the topic is about: Home Homepage Membership Levels General Discussion Complete Stock List Value Investing Forum Value Conference The book Podcast Membership Data Coverage Founder's Message Free Trial
Cranbrook Golf Club Closed,
Worst Computer Virus 2019,
Prince William Of Gloucester Cause Of Death,
Markham Pickleball Drop In,
South Columbus High School,